🇯🇵 Ubretid in Japan

PMDA authorised Ubretid on 5 September 1967

Marketing authorisation

PMDA — authorised 5 September 1967

  • Marketing authorisation holder: Torii Pharmaceuticals
  • Status: approved

Ubretid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Ubretid approved in Japan?

Yes. PMDA authorised it on 5 September 1967.

Who is the marketing authorisation holder for Ubretid in Japan?

Torii Pharmaceuticals holds the Japanese marketing authorisation.